Pear Therapeutics Employee Directory
Biotechnology ResearchMassachusetts, United States201-500 Employees
Pear Therapeutics is a Boston, Massachusetts-based biotechnology research company and the parent of Pear Therapeutics (US), Inc. It develops and commercializes prescription digital therapeutics, software-based medicines designed to treat disease and improve outcomes for patients, clinicians, and payers. The company operates an end-to-end platform to discover, develop, and deliver PDTs, with a pipeline across therapeutic areas and FDA disease-treatment claims, including reSET, reSET-O, and Somryst. Pear serves clinicians, patients, and payers seeking better outcomes, engagement, and cost-effective care, and it trades publicly on Nasdaq under the symbol PEAR. In May 2025, the company announced a collaboration with businessboxme.com to develop a digital therapeutic solution targeting substance use disorders.